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Objective. To compare the diﬀerence of imprinting status of insulin-like growth factor II (IGF-II) gene in villus between normal
embryo development group and abnormal embryo development group and to investigate the relationship between karyotype and
the imprinting status of IGF-II gene. Methods. A total of 85 pregnant women with singleton pregnancy were divided into two
groups: one with abnormal embryo development (n = 38) and the other with normal embryo development (n = 47). Apa I
polymorphism of IGF-II gene in chorionic villus was assayed with reverse transcriptase polymerase chain reaction (RT-PCR) and
restriction fragment length polymorphism (RFLP). The relationship between chromosomal abnormal karyotype and IGF-II gene
imprintingstatuswasanalyzedbyprimarycellcultureandG-bandingchromosomalkaryotypeanalysis.Results.IGF-IIimprinting
loss rate was higher in the abnormal embryo development group than the normal embryo development group (44.7% versus
31.6%),butwithoutsigniﬁcantdiﬀerence(P>. 05).Thepercentageofabnormalchromosomesofchorionicvillusintheabnormal
embryo development group was 42.5%, in which IGF-II imprinting loss rate reached 64.7%. No abnormal karyotypes were found
in the normal embryo development group. However, there was signiﬁcant diﬀerence in IGF-II imprinting loss rate between two
groups (P>. 05). Conclusion. During weeks 6–10 of gestation, abnormal embryonic development is correlated with chromosomal
abnormalities. The imprinting status of IGF-II gene played important roles in embryonic development, and imprinting loss might
be related to chromosomal abnormalities.
1.Introduction
Genomic imprinting (also, namely, gene imprinting) is an
epigenetic phenomenon inconsistent with the traditional
Mendelian inheritance. The deﬁnition of genomic imprint-
ing is that alleles from father or mother are modiﬁed when
they transmit genetic information to oﬀspring, resulting
in only one of alleles from father or mother expressed in
oﬀspring [1]. Imprinting is a dynamic process. It must
be possible to erase and re-establish the imprint through
each generation. The nature of the imprint must therefore
be epigenetic (modiﬁcations to the structure of the DNA
rather than the sequence). The majority of imprinted genes
are related with embryonic development. The parental-
speciﬁc expression is obtained through epigenetic modiﬁca-
tions (DNA methylation, histone tail modiﬁcations) which
alter the conformation of chromatin ﬁber and therefore
regulate the expression of the underlying genes. Deletions,
duplication, mutations, or alterations of imprinting of the
only active allele as well as uniparental sisomy or loss of
imprinting of the inactive allele lead to and unbalance (loss
of function or gain of function) in the dosage of the gene
product and may have phenotypic consequences.
Insulin-like growth factors (IGFs) are polypeptides that
play an important role in cellular proliferation and dif-
ferentiation. Insulin-like growth factor II (IGF-II) is an
important factor of human early embryo and placenta
development, and its roles are closely related with the gene
imprinting status [2]. Thus, gene imprinting loss will lead
to abnormal embryonic development. During the process
o fh u m a nf e t a ld e v e l o p m e n t ,3t o8g e s t a t i o n a lw e e k sa r e
the most important. Any factor impacting nutrition supply
and transmission of embryonic growth and development
can result in abnormal diﬀerentiation of embryos and
abortion. Spontaneous abortion accounts for 10–15% of all
pregnancies and the majority of them are early spontaneous2 Obstetrics and Gynecology International
abortion. At present, embryonic chromosomal abnormality
is a recognized etiological factor. Therefore, we detected
IGF-II gene imprinting status and chromosomal karyotype
of villus in patients with embryonic growth arrest and
investigate the relationship between them.
2.MaterialsandMethods
2.1. Subjects. Case group: 47 pregnant women who visited
outpatient clinic of family planning and eugenic genetics in
First Aﬃliated Hospital of Sun Yat-sen University because
of single gestation sac, empty embryo pregnancy, and
embryonic development arrest from April 2002 to January
2004 were enrolled in this study. The informed consent
was obtained from all subjects before participating in this
study. The inclusion criteria of this group included: B-type
ultrasonography that revealed embryonic growth arrest or
no embryo observed by repeated B-type ultrasonography;
regular menstrual cycle 3 months before pregnancy; 6–10
gestational weeks; no case history of endocrine diseases
and cancer; no administration with hormone drugs dur-
ing pregnancy; serum Toxplasma (TOX), Nubbavirs (RV),
Cytomegalo virus (CMV), Herpes simplex virus (HSV)
infection detection was negative. In this group, the mean age
was26.7+0.2yearsandthemeangestationalagewas7.2+0.1
weeks.
Control group: at the same time, 38 women of normal
early pregnancy with single gestation sac were randomly
selected. B-type ultrasonography revealed that embryonic
development was normal as well as embryo and fetal heart
beat. In this group, the mean age was 27.3+0 .3y e a r sa n d
the mean gestational age was 6.9+0 .2 weeks. There were no
signiﬁcant diﬀerences in age, gestational age, and number of
pregnancies between the two groups.
2.2. Methods
2.2.1. Chorionic Villus Cell Culture and Chromosome Analysis.
Chorionic villus cell culture: During the termination by
artiﬁcial abortion, chorionic villi were collected under sterile
conditionsthendissectedunderadissectingmicroscope.The
dissected chorionic villi were separated and washed repeat-
edly with ice-cold normal saline to remove attached blood
anddeciduas,thenshredded,digestedwith0.25%trypsinfor
5min, followed by centrifugation at 1000r/min for 10min,
and discarding supernatant. Subsequently, 1ml collagenase
II (sigma company, USA) was added into the sediments.
5min later, supernatant was removed after centrifugation
at 1000r/min, and the sediments were resuspended in
2ml complete medium (Complete Amnio Max, Invitrigen
company,USA),andcellsuspensionwastransferredintotwo
ﬂasks (about 1ml). Cell growth was daily observed under
invertedmicroscope.Whencellfusionandgoodvitalitywere
found in 40%–50% of cells, the cells were harvested for
chromosome analysis.
G-banding chromosome preparation: Colchicine
(0.15μg/ml ﬁnal concentration) was added in the harvested
cell suspensions. Subsequently, the mixture was put
in a 37◦C water bath for 60min, followed by adding
2ml preﬁxing liquid, mixing, centrifugation, discarding
supernatant, ﬁxation with 6ml 1:3 ﬁxing solution for
2min, centrifugation for 10min, discarding supernatant,
adding 60% acetic acid, 2ml methanol 2-3min later,
mixing, centrifugation, discarding supernatant, ﬁxation
with 4ml 1:3 ﬁxing solution for 1h, discarding supernatant,
preparing 1-2 conventional G-banding chromosome. At
least 15 splitphases were observed, and karyotype analysis
w a sp e r f o r m e di n3p h a s e si ne a c hs p e c i m e n .
2.2.2. Detection of IGF-II Gene Polymorphism. Chorionic
villus genomic DNA was extracted with saturated phenol
and chloroform, and then IGF-II gene polymorphism was
detected by polymerase chain reaction (PCR)-restriction
fragment length polymorphism analysis. The total volume
of PCR reaction system was 50μL, including template DNA
600ng,10×PCRreactionsolution5μL,10U/μLT aqenzyme
(TaKaRaInc.,Japan)0.5L,10mmol/LdNTPs1μL,upstream
primer 1μL, and downstream primer 1μL( d e s i g nf o rA p a
I polymorphic restriction site of 9th exon of IGF-II gene).
PCR reaction conditions were as follows: predenaturation
at 94◦C for 5min, 35 cycles of denaturation at 94◦Cf o r
s, annealing at 55◦C for 40s and extension at 72◦Cf o r
40s, ﬁnal extension at 72◦C for 7min. IGF-II gene PCR
products (236bp) were digested overnight at 25◦Cw i t h
restrictionenzymeApaI(BioLabs).Subsequently,theirgeno-
types were analyzed with 1.5% agarose gel electrophoresis.
IGF-II genes expressed diallele (236bp, 173bp and 63bp
fragments (type AB)), indicating that the loss of imprinting
occurred while monoalle (only 236bp fragment (type A)
or only 173bp and 63bp fragments (type B)), indicating
normal imprinting status. IGF-II upstream and downstream
primers were 5 -CTTGGACTTTGACTCAAATTGG-3 and
5 -CCTCCTTTGGTCTTACTGGG-3 ,r e s p e c t i v e l y .
2.2.3. IGF-II Gene Imprinting Status Detection. Chorionic
villus IGF-II gene imprinting status was detected by reverse
transcription-polymerasechainreaction(RT-PCR)andApaI
restriction enzyme digestion. Heterozygous genomic DNA
specimens (type AB) were selected to extract RNA. QIAGEN
Poly A+ mRNA extraction kit (Germany) and RT-PCR (two-
step) kit (Invitrigen company, USA) were used in this study
following the instructions. PCR reaction and Apa I restric-
tion enzyme digestion method of RT-PCR products were
similar to IGF-II gene polymorphism detection (Figure 1).
2.2.4. Statistical Analyses. All statistical analyses were per-
formed by SPSS version 13.0 statistical software. The data in
each group is presented as the mean ± SD, and comparison
between groups was determined by χ2 test, with P<. 05
considered signiﬁcant.
3. Results
3.1. Primary Culture of Chorionic Villus Cells and Chro-
mosome Karyotype Analysis. In this study, a total of 47
cases of chorionic villus were cultured in the abnormalObstetrics and Gynecology International 3
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Figure 1: IGF-II gene imprinting status detected by RT-PCR.
Table 1: Villus karyotype analysis of embryonic maldevelopment.
Chromosomal
abnormality type Caryotype n
Trisomy 47, XX (XY), +21 4
47, XX (XY), +8 1
47, XX (XY), +13 2
Triplont 69, XXX 3
69, XXY 2
Haplotype 45, XO 1
Other 46, XY, t (9; 22) (p13; p12) 1
46, XX/46, XY 1
46, XX, del (5) (p15) 1
46, XX,
i(10)(qter→cen→qter) 1
Total 17
embryonic development group, including culture failure in
6 cases, primary culture failure in 1 case because of villus
degeneration, with a failure rate of 15%, while 38 cases in
the normal embryonic development group were successfully
cultured. The mean culture time in abnormal and normal
embryonic development groups was 13.1 ± 1.4dand6.8 ±
0.9d, respectively. Obviously, the former was twice longer
than the latter in culture time, which might be related with
the long time embryonic death, would cause villus necrosis,
low activity.
G-banding chromosome karyotype analysis of chorionic
villus was normal in the normal embryonic development
group while abnormal karyotype was 17 cases (42.5%) in
theabnormalembryonicdevelopmentgroup,includingmale
karyotype in 6 cases, female karyotype in 5 cases, 45, XO in
one case, 69, XXX in three cases and 69, XXY in 2 cases. One
case of cat cry syndrome suﬀered from dead fetus at one time
and induced abortion was performed in second pregnancy
because cord blood chromosome analysis revealed cat cry
syndrome. This unwanted pregnancy expressed embryonic
development arrest, and its chorionic villus chromosomes
were 46, XX and del (5) (p15). The detailed karyotypes were
as shown in Table 1.
3.2. Villus IGF-II Gene Imprinting Status. In the abnormal
embryonic development group, the imprinting loss rate of
IGF-II gene was 44.7%, which was higher than 31.6% in the
Table 2: IGF-II gene imprinting status in the abnormal and normal
embryonic development groups.
Group Genotype AA/BB AB
n % n %
Normal group 26 68.4 12 31.6
Abnormal group 26 55.3 21 44.7
(chromosomal abnormality) 6 35.3 11 64.7
A, B, and AB indicates three kinds of genetic imprinting status, AA/BB
indicate normal imprinting, AB indicates gene imprinting loss.
normal group, but without signiﬁcant diﬀerence (χ2 = 1.52,
P>. 05). Gene imprinting loss rate of embryonic villus
karyotype was similar between male and female, without
signiﬁcant diﬀerence (Table 2).
The chromosomal abnormality rate was 42.5% in the
abnormal embryonic development group. Of 17 specimens
with abnormal karyotypes, 11 cases suﬀered from IGF-II
gene imprinting loss, with the loss rate up to 64.7%. While,
no abnormal villus chromosomal karyotype analysis was
found in the normal embryonic development group. There
was no signiﬁcant diﬀerence between two groups (χ2 = 5.3,
P<. 05).
4. Comment
4.1. Primary Culture of Chorionic Villus Cells in Embryonic
Development Arrest. The culture time of chorionic villus
cells from abortion or dead fetus depended on cell survival
rate. The culture time was up to 3 to 4 weeks if there were
less active cells in tissues. Culture failure was deﬁned as
cell growth arrest for more than one month [3]. There-
fore, timely specimen collection was crucial for successful
chromosomal detection for villus in embryonic development
arrest. In 2002, Greenwold and Jauniaux [4] reported that
ultrasound-guided sucking villus from early spontaneous
abortion could obtain only 4.5% of villus cell culture failure
rate. In this study, the specimens were collected by vacuum
uterine aspiration, which was easily polluted by vaginal
secretions. However, intrauterine collection for villus could
reducetherisk ofpollution andimprove culturesurvivalrate
of villus.
Villus culture in 40 cases of embryonic development
arrest showed that chromosomal abnormality was 42.5%,
indicating that nearly one half of fetus with chromosomal
diseases (the majority was severe chromosomal abnormali-
ties, resulting in severe imbalance of genetic materials) could
not survive to birth, due to natural selection. Except chro-
mosome 1, triplont was found in all human chromosomes.
Of them, triplont in chromosome 1 accounted for one third
ofalltriplonts andwasonekind ofhighlylethaltriplont. The
other common triplonts included triplonts in chromosomes
21 and 22 [5]. Except triplont in chromosome 21, other
triplonts could not survive [6]. Autosomal triplont was
the most common chromosomal abnormality in embryos.
The experimental ﬁndings in this study conﬁrmed this
phenomenon.4 Obstetrics and Gynecology International
4.2.IGF-IIGeneImprintingLossandEmbryonicDevelopment.
The balance of cell apoptosis and proliferation was crucial to
maintain pregnancy, and its functional regulation disorder
might lead to early embryonic development arrest. Warner
deemed that the dynamic balance of speed of development
and apoptosis was an internal factor of embryo survival.
In the process of embryonic development, development
and apoptosis-related genes, cytokines and corresponding
receptors played important roles in embryonic survival [7].
Imprinted genes of germ cells cycled with reproductive
cycle through three phases of erase, formation, and main-
tenance. After fertilization, the majority of genes experi-
enced re-demethylation, while imprinted genes maintained
original methylation status before and after fertilization and
nidation due to the protection of diﬀerentially methylated
regions. Meanwhile, internal and external environment
changes could lead to genetic alternations and gene imprint-
ing loss. This study showed that IGF-II gene imprinting
loss in the embryonic development arrest group was slightly
higherthanthenormalgroup,withoutsigniﬁcantdiﬀerence.
However, IGF-II gene imprinting loss of 17 abnormal kary-
otypes in the abnormal embryonic development group was
signiﬁcantlyhigherthanthenormalembryonicdevelopment
group. Thus, we speculated that chromosomal abnormalities
of embryos could result in abnormal function expression of
regulatory genes in early embryonic development, leading to
increased IGF-II gene imprinting loss, which might destroy
the balance between villus and deciduas, leading to shallow
embryoimplantation,spontaneousabortion,andembryonic
development arrest. However, the collected data in this study
was relatively less, and thus there should be a bigger sample
size,tofurtherdiscussandexplorewhetherIGF-2imprinting
loss was a new molecular genetic marker of spontaneous
abortion or not.
Some scholars believe that IGF-II gene imprinting loss
leads to overexpression [8, 9] because gene imprinting loss
activates the original silent mother-derived alleles, resulting
in two times of gene expression level and signiﬁcantly
elevated IGF-II protein expression. It was also deemed
that IGF-II gene imprinting loss could result in overgrow
diseases, including Beckwith-Wiedemann syndrome (BWS)
as well as “fetal overgrowth syndrome”, resulting in prenatal
overgrowth, polyhydramnios, fetal, and neonatal deaths.
However, some scholars also concluded that there were no
signiﬁcant correlation between IGF-II gene imprinting loss
and IGF-II protein overexpression, and even IGF-II gene
imprinting loss resulted in the downregulation of IGF-II
proteinexpression[10–12].VambergueAetal.foundthatno
loss of genomic imprinting of IGF-II in placentas of diabetic
pregnancies with fetal macrosomia [13].
There might be a lot of complicated middle links
between IGF-II gene imprinting loss and IGF-II expression
regulation.
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